TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
CTMX

CytomX Therapeutics Inc

Healthcare · Biotechnology

2.00$ +0.0% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns CytomX Therapeutics Inc (CTMX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 82.5% of the shares are freely tradable; institutional investors hold 105.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 105.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 82.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 23.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 218Mio.

Largest Shareholders

Institutions

Institutions CTMX
Name Stake (%) Shares Change (%) Date
FMR Inc 15.01 32,714,937 +2.4 06/30/2026
Kynam Capital Management, LP 9.96 21,703,093 +44.6 06/30/2026
BlackRock Inc 8.05 17,559,822 +235.9 06/30/2026
Bank of America Corp 6.92 15,082,617 +47.8 06/30/2026
State Street Corp 5.39 11,747,236 +107.4 06/30/2026
Perceptive Advisors LLC 4.79 10,439,185 +3.4 06/30/2026
Vanguard Capital Management, LLC 3.91 8,525,457 -2.4 06/30/2026
Point72 Asset Management, L.P. 3.58 7,811,033 -0.8 06/30/2026

Funds

Funds CTMX
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.86 6,230,387 +0.0 09/30/2026
Fidelity Select Health Care 2.75 6,000,000 +20.0 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?